Tech Company Financing Transactions

Beam Therapeutics Funding Round

Arch Venture Partners, F-Prime Capital and private investors participated in a $87 million Series A venture round for Beam Therapeutics. The financing round was announced on 5/15/2018.

Transaction Overview

Company Name
Announced On
5/15/2018
Transaction Type
Venture Equity
Amount
$87,000,000
Round
Series A
Investors

Arch Venture Partners (Lead Investor) (Robert Nelsen)

F-Prime Capital (Lead Investor) (Stephen Knight)

Proceeds Purpose
Beam aims to use these technologies to generate a broad pipeline of precision genetic medicines that repair disease-causing point mutations, write in protective genetic variations, or modulate the expression or function of disease-causing genes.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
26 Landsdowne St. 2nd Floor
Cambridge, MA 02139
USA
Phone
Undisclosed
Email Address
Overview
Beam Therapeutics is pioneering the use of CRISPR base editing to develop precision genetic medicines that treat disease, one letter at a time.
Profile
Beam Therapeutics LinkedIn Company Profile
Social Media
Beam Therapeutics Company Twitter Account
Company News
Beam Therapeutics News
Facebook
Beam Therapeutics on Facebook
YouTube
Beam Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Evans
  John Evans LinkedIn Profile  John Evans Twitter Account  John Evans News  John Evans on Facebook
Chief Scientific Officer
Giuseppe Ciaramella
  Giuseppe Ciaramella LinkedIn Profile  Giuseppe Ciaramella Twitter Account  Giuseppe Ciaramella News  Giuseppe Ciaramella on Facebook
Co-Founder
Keith Joung
  Keith Joung LinkedIn Profile  Keith Joung Twitter Account  Keith Joung News  Keith Joung on Facebook
Co-Founder
David Liu
  David Liu LinkedIn Profile  David Liu Twitter Account  David Liu News  David Liu on Facebook
Co-Founder
Feng Zhang
  Feng Zhang LinkedIn Profile  Feng Zhang Twitter Account  Feng Zhang News  Feng Zhang on Facebook
Vice President
Francine Gregoire
  Francine Gregoire LinkedIn Profile  Francine Gregoire Twitter Account  Francine Gregoire News  Francine Gregoire on Facebook
Vice President
Dana Levasseur
  Dana Levasseur LinkedIn Profile  Dana Levasseur Twitter Account  Dana Levasseur News  Dana Levasseur on Facebook
VP - Bus. Development
Courtney Wallace
  Courtney Wallace LinkedIn Profile  Courtney Wallace Twitter Account  Courtney Wallace News  Courtney Wallace on Facebook
VP - Finance
Suzanne Fleming
  Suzanne Fleming LinkedIn Profile  Suzanne Fleming Twitter Account  Suzanne Fleming News  Suzanne Fleming on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/15/2018: Firepoint venture capital transaction
Next: 5/15/2018: Alloy.ai venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary